Inhibrx Biosciences, Inc
6 clinical trials · Sponsor
◉ Watch Inhibrx Biosciences, Inc
| Record | Firm | Date |
|---|---|---|
| Study of INBRX-109 in Conventional Chondrosarcoma (NCT04950075) | Inhibrx Biosciences, Inc | 2021-09-23 |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) (NCT04198766) | Inhibrx Biosciences, Inc | 2019-12-10 |
| Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency (NCT03815396) | Inhibrx Biosciences, Inc | 2019-07-19 |
| Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (NCT03809624) | Inhibrx Biosciences, Inc | 2019-01-30 |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas (NCT03715933) | Inhibrx Biosciences, Inc | 2018-10-08 |
Track Inhibrx Biosciences, Inc automatically
Every clearance here is in the API, with alerts when new ones post.